Sort   by:  
 Page size 
UnknownCombination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study.
Not available
S-EPMC3392072 | biostudies-literature
UnknownProgrammed death-1 checkpoint blockade in acute myeloid leukemia.
Not available
S-EPMC4778424 | biostudies-literature
UnknownTime from diagnosis to treatment is associated with survival in patients with acute myeloid leukaemia: An analysis of 55 985 patients from the National Cancer Database.
Not available
S-EPMC9547942 | biostudies-literature
UnknownBlast-Derived Small Extracellular Vesicles in the Plasma of Patients with Acute Myeloid Leukemia Predict Responses to Chemotherapy.
Not available
S-EPMC10740822 | biostudies-literature
UnknownCirculating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.
Not available
S-EPMC5666018 | biostudies-literature
UnknownDNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
Not available
S-EPMC4234093 | biostudies-literature
UnknownTriggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
Not available
S-EPMC3708458 | biostudies-literature
UnknownF-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.
Not available
S-EPMC3321873 | biostudies-literature
UnknownA phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia.
Not available
S-EPMC6201295 | biostudies-literature
UnknownPhase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.
Not available
S-EPMC11552450 | biostudies-literature
Sort   by:  
 Page size